市场调查报告书
商品编码
1452587
欧洲家禽诊断市场预测至 2030 年 - 区域分析 - 按测试类型和疾病(禽沙门氏菌病、禽流感、新城疫、禽支原体病、传染性支气管炎等)Europe Poultry Diagnostic Market Forecast to 2030 - Regional Analysis - By Test Type and Disease (Avian Salmonellosis, Avian Influenza, Newcastle Disease, Avian Mycoplasmosis, Infectious Bronchitis, and Others) |
欧洲家禽诊断市场预计将从2022年的5,450万美元成长到2030年的1.2,136亿美元。预计2022年至2030年CAGR为10.5%。
政府支持和措施推动欧洲家禽诊断市场
在欧洲,各国政府优先考虑严格的监管框架,以维护家禽业的完整性和安全性。例如,欧盟 (EU) 实施由欧盟委员会健康与食品安全总司 (DG SANTE) 监督的综合法规。这些法规包括旨在保障家禽健康的严格的生物安全措施、疾病预防方案和卫生标准。
荷兰和法国等欧盟国家拥有自己的国家监管机构,其工作符合欧盟标准。此外,荷兰食品和消费品安全局 (NVWA) 也在全国家禽养殖场监督和执行严格的生物安全措施和疾病管制协议。同样,法国农业和食品部确保实施强有力的法规,重点关注疾病预防、疫苗接种计划和严格监测家禽健康。
此外,欧洲食品安全管理局 (EFSA) 在获取家禽健康相关潜在风险并提供科学建议方面发挥至关重要的作用,有助于在整个欧盟制定和实施有效的监管措施。
欧洲各地这些严格的监管框架强调了确保家禽健康、安全和品质高标准的承诺。它们强调了该地区致力于维护国际标准、确保消费者信心并保持欧洲家禽业的竞争力。
欧洲家禽诊断市场概况
欧洲家禽诊断市场分为德国、英国、法国、义大利、西班牙和欧洲其他地区。不断增加的家禽疾病和政府为克服这种情况而采取的倡议是推动欧洲市场成长的主要因素。欧盟实施了针对人畜共通传染病的扩展控制计划,其中沙门氏菌被列为优先事项。这些计划包括提供科学建议和限制受感染鸡群产品的贸易。德国欧洲家禽诊断市场的推动因素包括新测试创新的研发活动增加、家禽中禽流感等传染病流行率的上升以及新测试的采用。 2020年11月至2021年5月期间,德国遭遇了有史以来最大规模的高致病性禽流感疫情,家禽和圈养鸟类爆发了245起疫情,野生鸟类确诊病例超过1000例。 2021年3月,一家待售蛋鸡饲养场确认爆发H5N8型高致病性禽流感疫情。 2020 年,在下萨克森州的一个家禽养殖场检测到了德国 HPAI 的 H5N8 病毒变种。因此,预计上述因素将在预测期内推动德国的欧洲家禽诊断市场。
欧洲家禽诊断市场收入及 2030 年预测(百万美元)
欧洲家禽诊断市场细分
欧洲家禽诊断市场分为测试类型、疾病和国家。
根据测试类型,欧洲家禽诊断市场分为酵素连结免疫吸附测定(ELISA)测试、聚合酶链反应(PCR)测试、血凝抑制(HI)测试等。 2022 年,酶联免疫吸附测定 (ELISA) 测试领域占据欧洲家禽诊断市场的最大份额。
疾病方面,欧洲家禽诊断市场分为禽流感、传染性支气管炎、禽沙门氏菌病、新城疫、禽支原体病等。 2022 年,禽流感细分市场在欧洲家禽诊断市场中占据最大份额。
按国家/地区划分,欧洲家禽诊断市场分为德国、西班牙、法国、英国、义大利和欧洲其他地区。德国在 2022 年主导欧洲家禽诊断市场。
Thermo Fisher Scientific Inc、Idex Laboratories Inc、Qiagen NV、Eurofins Scientific SE、IDVET、Boehringer Ingelheim International GmbH、Zoetis Inc、BioCheck BV 和 BioInGenTech Biotechnologies 是欧洲家禽诊断市场上的一些领先公司。
The Europe poultry diagnostic market is expected to grow from US$ 54.50 million in 2022 to US$ 121.36 million by 2030. It is estimated to grow at a CAGR of 10.5% from 2022 to 2030.
Government Support and Initiatives Fuel Europe Poultry Diagnostic Market
In Europe, governments prioritize stringent regulatory frameworks to uphold the integrity and safety of the poultry industry. For instance, the European Union (EU) implements comprehensive regulations overseen by the European Commission's Directorate-General for Health and Food Safety (DG SANTE). These regulations encompass strict biosecurity measures, disease prevention protocols, and hygiene standards aimed at safeguarding poultry health.
Countries within the EU, such as the Netherlands and France, have their own national regulatory bodies that work in alignment with EU standards. Additionally, the Netherlands Food and Consumer Product Safety Authority (NVWA) monitors and enforces stringent biosecurity measures and disease control protocols in poultry farms across the country. Similarly, France's Ministry of Agriculture and Food ensures the implementation of robust regulations, focusing on disease prevention, vaccination programs, and strict monitoring of poultry health.
Additionally, the European Food Safety and Authority (EFSA) plays a crucial role in accessing and providing scientific advice on potential risks related to poultry health, contributing to the development and implementation of effective regulatory measures across the EU.
These stringent regulatory frameworks across Europe emphasize the commitment to ensuring high standards of poultry health, safety, and quality. They underscore the region's dedication to upholding international standards, ensuring consumer confidence, and maintaining the competitiveness of the European poultry industry.
Europe Poultry Diagnostic Market Overview
The Europe poultry diagnostic market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The rising poultry diseases and government initiatives to overcome the situation are the major factors driving the market growth in Europe. The EU implemented extended control programs for zoonotic diseases, with Salmonella set as a priority. These programs include the provision of scientific advice and limitations on the trade of products from infected flocks. The Europe poultry diagnostic market in Germany is driven by increased R&D activities for the innovation of newer tests, a rise in the prevalence of infectious diseases such as bird flu in poultry, and the adoption of newer tests. Between November 2020 and May 2021, Germany faced the largest epidemic recorded of HPAI, with 245 outbreaks in poultry and captive birds and more than 1,000 diagnosed cases in wild birds. In March 2021, an HPAI outbreak of subtype H5N8 was confirmed in a holding rearing laying hens for sale. The H5N8 virus variant of HPAI in Germany was detected at a poultry farm in Lower Saxony in 2020. Thus, the abovementioned factors are expected to drive the Europe poultry diagnostic market in Germany during the forecast period.
Europe Poultry Diagnostic Market Revenue and Forecast to 2030 (US$ Million)
Europe Poultry Diagnostic Market Segmentation
The Europe poultry diagnostic market is segmented into test type, disease, and country.
Based on test type, the Europe poultry diagnostic market is segmented into enzyme-linked immunosorbent assay (ELISA) tests, polymerase chain reaction (PCR) tests, hemagglutination-inhibition (HI), and others. The enzyme-linked immunosorbent assay (ELISA) tests segment held the largest share of the Europe poultry diagnostic market in 2022.
In terms of disease, the Europe poultry diagnostic market is segmented into Avian Influenza, Infectious Bronchitis, Avian Salmonellosis, Newcastle Disease, Avian Mycoplasmosis, and Others. The Avian Influenza segment held the largest share of the Europe poultry diagnostic market in 2022.
By country, the Europe poultry diagnostic market is segmented into the Germany, Spain, France, UK, Italy, and the Rest of Europe. The Germany dominated the Europe poultry diagnostic market in 2022.
Thermo Fisher Scientific Inc, Idexx Laboratories Inc, Qiagen NV, Eurofins Scientific SE, IDVET, Boehringer Ingelheim International GmbH, Zoetis Inc, BioCheck BV, and BioInGenTech Biotechnologies are some of the leading companies operating in the Europe poultry diagnostic market.